A Grassroots Group Urged Missouri's AG To Investigate Pfizer. Then Came the Money.

Shortly after Republican Andrew Bailey was appointed as Missouri's 44th attorney general last year, a grassroots conservative group wrote him with a request: Join Florida in investigating Pfizer and other "Big Pharma" companies over the promotion and pricing of their COVID vaccines.

The post A Grassroots Group Urged Missouri's AG To Investigate Pfizer. Then Came the Money. appeared first on .

Court: Doctors Threatened For Questioning The Covid Regime Can Sue Tyrannical Credentialing Boards

The ruling is a huge win for patients seeking medical freedom and for doctors who questioned the government's Covid narratives.

Biden Admin Pressured FDA To Fast Track Covid Vaccines, House Report Finds

The report revealed the FDA failed to follow traditional regulatory standards.

FACT CHECK: Threads Post Makes False Claim About Bourla’s Comments On COVID-19 Pandemic

A post shared on Threads claims Pfizer CEO Albert Bourla recently admitted COVID-19 was a “test.”   Post by @cj_wirenut View on Threads   Verdict: False The original video shows that comments Bourla made at the Economic Club of Chicago in February 2023 were taken out of context. A spokesperson for Pfizer denied the claim’s […]

Pharmaceutical Industry Is Bankrolling Obesity Group That Promotes ‘Body Positivity’

An obesity group determined to destigmatize obesity on behalf of Big Pharma is akin to Big Tobacco funding projects to destigmatize smoking.

Kansas AG Sues Pfizer For ‘Falsely Representing’ And ‘Suppressing The Truth’ About Its Covid Jab

Kobach's lawsuit makes Kansas the third state to take action against Covid shot manufacturers for purportedly misleading consumers.

Four Years Later, Conservative Voters Haven’t Forgotten How Covid Tyrants Acted In Crisis

Republicans’ long memory for totalitarianism is much more visible on the local level where candidates try to erase their Covid-era behavior.

Pfizer chemical spill in Michigan causes local authorities to issue no-contact advisory of Kalamazoo River

[rebelmouse-proxy-image https://www.theblaze.com/media-library/pfizer-chemical-spill-in-michigan-causes-local-authorities-to-issue-no-contact-advisory-of-kalamazoo-river.jpg?id=51762523&width=1245&height=700&coordinates=0,53,0,54 crop_info="%7B%22image%22%3A%20%22https%3A//www.theblaze.com/media-library/pfizer-chemical-spill-in-michigan-causes-local-authorities-to-issue-no-contact-advisory-of-kalamazoo-river.jpg%3Fid%3D51762523%26width%3D1245%26height%3D700%26coordinates%3D0%2C53%2C0%2C54%22%7D" expand=1]

Pfizer has admitted to a chemical spill into the Kalamazoo River, which prompted local authorities to issue a no-contact advisory for the river in Kalamazoo, Michigan. Government health agencies have declared the chemical involved in the spill to be a possible carcinogen and potentially deadly in high doses. However, Pfizer has said that it does "not anticipate any health risks."

Pfizer notified the Kalamazoo Department of Public Services about the chemical spill around 4:30 p.m. on March 12. The pharmaceutical giant revealed that it had leaked an estimated 1,057 gallons of methylene chloride within the process area of the company's manufacturing plant in Kalamazoo.

The city of Kalamazoo said in a statement, "An unknown amount of the colorless liquid was discharged into a dedicated sanitary sewer serving Pfizer, which then flows to the Kalamazoo Water Reclamation Plant (KWRP) for treatment."

The city noted that the Kalamazoo Water Reclamation Plant can only treat up to 291 gallons of methylene chloride per day.

Local officials issued a no-contact advisory for the Kalamazoo River.

"At this time, the Kalamazoo County Health & Community Services Department, in cooperation with the City of Kalamazoo Department of Public Services, are advising all persons to avoid contact with the Kalamazoo River from Paterson Street Bridge in the city of Kalamazoo to the D Ave Bridge in Cooper Township," said the statement from county and city officials.

Jim Rutherford, Kalamazoo County health officer, said, "This advisory will remain in effect until further investigation, and sampling indicates that there is no risk to public health."

Pfizer asserted, "Given the amount of the discharge and controls in place, we do not anticipate any health risks."

"Pfizer will continue to work with the City of Kalamazoo and is firmly committed to assessing and minimizing any potential impacts on human health, the environment, and the communities in which it operates," the pharmaceutical company stated.

According to the Centers for Disease Control and Prevention, "Methylene chloride (CH2Cl2) is a colorless liquid that can harm the eyes, skin, liver, and heart. Exposure can cause drowsiness, dizziness, numbness and tingling limbs, and nausea. It may cause cancer. Severe exposure can cause loss of consciousness and death."

Besides being used in pharmaceutical manufacturing, methylene chloride is found in paint strippers, metal cleaners, adhesives, and lubricants.

According to the Occupational Safety and Health Administration, 17 American workers died while using methylene chloride paint-stripping products to refinish bathtubs between 2000 and 2015.

OSHA considers methylene chloride to be a potential occupational carcinogen.

The Environmental Protection Agency classifies methylene chloride as a "toxic waste when a discarded commercial chemical product or manufacturing chemical intermediate or an off-specification commercial chemical product or manufacturing chemical intermediate."

The Kalamazoo location is Pfizer's largest pharmaceutical manufacturing plant, according to the company.

The 1,300-acre facility manufactures active pharmaceutical ingredients, drug products, and medical devices. Each year, the Kalamazoo facility produces 1,200 metric tons of products.

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Pfizer assures no health risks after methylene chloride spill in Kalamazoo www.youtube.com

Blood clots, neurological disorders, and swollen hearts: Multinational study on COVID vaccines paints a damning picture

[rebelmouse-proxy-image https://www.theblaze.com/media-library/blood-clots-neurological-disorders-and-swollen-hearts-multinational-study-on-covid-vaccines-paints-a-damning-picture.jpg?id=51510782&width=1200&height=400&coordinates=0,62,0,273 crop_info="%7B%22image%22%3A%20%22https%3A//www.theblaze.com/media-library/blood-clots-neurological-disorders-and-swollen-hearts-multinational-study-on-covid-vaccines-paints-a-damning-picture.jpg%3Fid%3D51510782%26width%3D1200%26height%3D400%26coordinates%3D0%2C62%2C0%2C273%22%7D" expand=1]

Those skeptical of the assertion that COVID-19 vaccines were altogether safe and effective — a claim long advanced by once-trusted government agencies, pharmaceutical companies, and the media amidst a historic censorship campaign targeting dissenters and critics — appear to have had their doubts once again validated.

A damning new peer-reviewed multinational study examining data from nearly 100 million people has not only affirmed the well-documented link between the COVID-19 vaccines and increased risk of heart conditions but has also highlighted troubling links between the AstraZeneca, Moderna, and Pfizer vaccines and medical conditions such as Guillain-Barré syndrome, brain and spinal cord inflammation, Bell's palsy, and convulsions.

The study was conducted by the Global COVID Vaccine Safety Project — a Global Vaccine Data Network initiative supported by both the Centers for Disease Control and Prevention and the Department of Health and Human Services — and published last week in the esteemed journal Vaccine, the official journal of the Japanese Society for Vaccinology.

Lead author Kristýna Faksová of the Department of Epidemiology Research at the Danish State's Serum Institute was joined by researchers from various other countries including Argentina, Australia, Canada, Finland, New Zealand, and Scotland in assessing whether there was a greater risk of 13 neurological, blood, and heart-related medical conditions occurring following the receipt of a COVID-19 vaccine.

According to the observed versus expected rates study, which included data on 99 million people vaccinated against SARS-CoV-2 across eight countries, "the risk up to 42 days after vaccination was generally similar to the background risk for the majority of outcomes; however, a few potential safety signals were identified."

"Bell's palsy had an increased OE ratio after a first dose of [Pfizer's] BNT162b2 and [Moderna's] mRNA-1273," said the study. "There were also increased OE ratios for febrile seizures following a first and second dose of mRNA-1273 ... and for generalized seizures following first mRNA-1273 dose and fourth BNT162b2 dose."

The researchers observed a trend of Guillain-Barré syndrome and cerebral venous sinus thrombosis — a type of blood clot in the brain — cases after viral vector vaccines such as the Oxford-AstraZeneca COVID-19 vaccine, which Canada and European nations ditched in spring 2021 over reports of dangerous blood clots.

The researchers specifically found a "statistically significant increase in GBS cases within 42 days after a first ChAdOx1 dose." Whereas they expected to find 76 GBS "events," they found well over twice as many.

The University of Auckland, which hosts the Global Vaccine Data Network, noted that the researchers found possible "safety signals for transverse myelitis (inflammation of part of the spinal cord) after viral vector vaccines and acute disseminated encephalomyelitis (inflammation and swelling in the brain and spinal cord) after viral vector and mRNA vaccines."

However, the paper cautioned that "although some case reports have suggested a possible association between COVID-19 vaccination and ADEM, there was no consistent pattern in terms of vaccine or timing following vaccination, and larger epidemiological studies have not confirmed any potential association."

The study did however confirm previously established safety signals for myocarditis and pericarditis following mRNA vaccination, highlighting "significantly higher risks of myocarditis following the first, second and third doses of BNT162b2 and mRNA-1273 as well as pericarditis after the first and fourth dose of mRNA-1273, and third dose of ChAdOx1, in the 0–42 days risk period."

According to the study, "Potential underreporting across countries may have led to an underestimation of the significance of potential safety signals" for viral vector and mRNA vaccines alike.

"The size of the population in this study increased the possibility of identifying rare potential vaccine safety signals," Faksová said in a statement. "Single sites or regions are unlikely to have a large enough population to detect very rare signals."

The researchers claimed that the "safety signals identified in this study should be evaluated in the context of their rarity, severity, and clinical relevance."

Additionally, they noted the "overall risk–benefit evaluations of vaccination should take the risk associated with infection into account, as multiple studies demonstrated higher risk of developing the events under study, such as GBS, myocarditis, or ADEM, following SARS-CoV-2 infection than vaccination."

Blaze News reported earlier this month that a peer-reviewed study published Jan. 24 in the Springer Nature Group journal Cureus suggested the COVID-19 vaccines were a rushed product with an "unacceptable harm-to-reward ratio."

The study noted that the kinds of serious adverse events that would be factored into a risk-benefit comparison "have often been wrongly ascribed to COVID-19 rather than to the COVID-19 mRNA vaccinations."

"Misattributions of SAEs to COVID-19 often may be due to the amplification of adverse effects when mRNA injections are followed by SARS-CoV-2 subvariant infection," said the study. "Injuries from the mRNA products overlap with both [post-acute COVID-19 syndrome] and severe acute COVID-19 illness, often obscuring the vaccines' etiologic contributions."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!